Skip to main content
Here’s the Safest Way to Get Insanely Rich in the 2021 Gold Bull Market
Gold is screaming higher and smart investors are already cashing in on the #1 Gold Pick of 2021. Yet, you haven’t missed the boat. See how this newly-listed US$5 gold stock offers investors historic gains without mining a single ounce of the metal.
Get the details here...

ONCR Insider Trading (Oncorus)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $4,875,015.00
Insider Selling (Last 12 Months): $730,344.15

Oncorus Insider Trading History Chart

Oncorus Share Price & Price History

▲ +0.26 (1.69%)
As of 05/7/2021 01:00 AM ET
Days: 30 | 90 | 365
Former U.S. Congressman—here’s how rich get richer
Former 12-term Congressman, Air Force surgeon, and Presidential candidate says both political parties are wrong about how the rich REALLY get richer. Take a few minutes to hear him explain what’s going on... what’s coming next... and most importantly, what YOU can do about it, starting right now.
Click here for details.

Oncorus Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/30/2021Christophe QuevaSVPSell23,555$15.97$376,173.3536,420View SEC Filing Icon  
4/28/2021Christophe QuevaSVPSell17,990$15.22$273,807.8077,376View SEC Filing Icon  
4/26/2021Christophe QuevaSVPSell54$15.00$810.0077,376View SEC Filing Icon  
4/6/2021Christophe QuevaSVPSell5,300$15.01$79,553.0077,430View SEC Filing Icon  
10/6/2020Luke EvninDirectorBuy151,225$15.00$2,268,375.00View SEC Filing Icon  
10/6/2020Sunstates Fund L.P. MpmMajor ShareholderBuy173,776$15.00$2,606,640.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Oncorus (NASDAQ:ONCR)

Institutional Buying and Selling by Quarter

Oncorus Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2021BlackRock Inc.363,018$5.05M0.0%+10.8%1.415%Search for SEC Filing on Google Icon
5/7/2021The PNC Financial Services Group Inc.21,244$0.30M0.0%+118.0%0.083%Search for SEC Filing on Google Icon
2/25/2021Hsbc Holdings PLC6,315$0.20M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.2,933$95K0.0%N/A0.013%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC10,863$0.35M0.0%N/A0.048%Search for SEC Filing on Google Icon
2/16/2021Janus Henderson Group PLC72,572$2.34M0.0%N/A0.321%Search for SEC Filing on Google Icon
2/16/2021Acuta Capital Partners LLC53,500$1.73M0.5%N/A0.237%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.38,953$1.26M0.0%N/A0.172%Search for SEC Filing on Google Icon
2/16/2021MPM Asset Management LLC2,849,464$92.12M13.0%N/A12.598%Search for SEC Filing on Google Icon
2/16/2021MPM Oncology Impact Management LP2,377,031$76.85M13.2%N/A10.509%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.3,850$0.12M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/12/2021CHI Advisors LLC1,679,906$54.31M15.3%N/A7.428%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp75,779$2.45M0.0%N/A0.335%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.1,225$40K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN3,446$0.11M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp17,468$0.57M0.0%N/A0.077%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund3,800$0.12M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/5/2021Letko Brosseau & Associates Inc.11,000$0.36M0.0%N/A0.049%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.327,721$10.60M0.0%N/A1.449%Search for SEC Filing on Google Icon
2/5/2021Fosun International Ltd962,321$31.11M2.0%N/A4.255%Search for SEC Filing on Google Icon
2/5/2021SG Americas Securities LLC9,103$0.29M0.0%N/A0.040%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Oncorus logo
Oncorus, Inc., a clinical stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. Oncorus, Inc. has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Read More on Oncorus

Today's Range

Now: $15.65

50 Day Range

MA: $14.37

52 Week Range

Now: $15.65


592,390 shs

Average Volume

177,698 shs

Market Capitalization

$401.42 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Oncorus?

Oncorus' top insider shareholders include:
  1. Christophe Queva (SVP)
  2. Luke Evnin (Director)
  3. Sunstates Fund LP Mpm (Major Shareholder)

Who are the major institutional investors of Oncorus?

Oncorus' top institutional investors include:
  1. BlackRock Inc. — 1.42%
  2. The PNC Financial Services Group Inc. — 0.08%

Which institutional investors are buying Oncorus stock?

During the last quarter, ONCR stock was purchased by institutional investors including:
  1. BlackRock Inc.
  2. The PNC Financial Services Group Inc.
Within the previous year, these company insiders have bought Oncorus stock:
  1. Christophe Queva (SVP)
  2. Luke Evnin (Director)
Ultra-Low-Priced Lithium Stock Offers Unlimited Upside in Global EV Boom
Lithium batteries are supplying our planet with clean reliable energy. EVs, laptops, cell name it. The Smart Money is going into the future suppliers of lithium like this US$0.15 stock that just secured a game-changing lithium asset.
Details Here.